Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Total Debt: 2014-2020

Historic Total Debt for Larimar Therapeutics (LRMR) over the last 5 years, with Mar 2020 value amounting to $6.7 million.

  • Larimar Therapeutics' Total Debt fell 50.12% to $6.7 million in Q1 2020 from the same period last year, while for Mar 2020 it was $6.7 million, marking a year-over-year decrease of 50.12%. This contributed to the annual value of $8.5 million for FY2019, which is 44.26% down from last year.
  • Latest data reveals that Larimar Therapeutics reported Total Debt of $6.7 million as of Q1 2020, which was down 20.29% from $8.5 million recorded in Q4 2019.
  • In the past 5 years, Larimar Therapeutics' Total Debt registered a high of $20.2 million during Q1 2018, and its lowest value of $1.2 million during Q3 2016.
  • Moreover, its 3-year median value for Total Debt was $13.5 million (2019), whereas its average is $13.5 million.
  • Data for Larimar Therapeutics' Total Debt shows a maximum YoY tumbled of 71.17% (in 2016) over the last 5 years.
  • Quarterly analysis of 5 years shows Larimar Therapeutics' Total Debt stood at $1.2 million in 2016, then reached $20.0 million in 2017, then declined by 24.08% to $15.2 million in 2018, then plummeted by 44.26% to $8.5 million in 2019, then tumbled by 50.12% to $6.7 million in 2020.
  • Its Total Debt was $6.7 million in Q1 2020, compared to $8.5 million in Q4 2019 and $10.2 million in Q3 2019.